Ferric maltol is an iron supplement used to treat or prevent anemia, a condition where the body doesn't have enough red blood cells. It provides iron that your body needs to make new red blood cells when diet alone isn't supplying enough.[2] Accrufer is currently approved and in use across 3 indications[4].[1]
Accrufer is one of 135 small molecule programs targeting Anemia. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
206 competitors in Heart Failure
Accrufer
Bayer Aspirin
Brethine
Medrol
Amidate
Zemplar
Adriamycin
Activase
Savaysa
Xifaxan
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jul 25, 2019
ACCRUFER
NDA NDA212320
Sources